Sign up
Pharma Capital
Showing 40 of 1108
Name Market Market Cap Share Price Daily Share Movement
1300 SMILES LIMITED ASX £77.04m £3.62 1.13% ico_glass.png
1ST DENTAL LABS PRIVATE £- £- - ico_glass.png
22nd Century Group Inc NYSE £291.23m £2.34 3.53% ico_glass.png
48North Cannabis Corp TSX-V £41.74m £0.40 -5.63% ico_glass.png
4D Pharma AIM £85.14m £1.30 46.07% ico_glass.png
AAC Holdings Inc NYSE £47.37m £1.93 -12.04% ico_glass.png
Abbvie NYSE £106,483.00m £70.79 0.49% ico_glass.png
Abeona Therapeutics NASDAQ £317.18m £6.62 3.89% ico_glass.png
ABIOMED NASDAQ £11,900.10m £264.22 0.78% ico_glass.png
abzena-logo.png Abzena PLC AIM £- £- - ico_glass.png
AC Immune Ltd NASDAQ £597.42m £8.87 -3.90% ico_glass.png
Acceleron Pharma Inc NASDAQ £1,764.80m £38.21 -0.13% ico_glass.png
Accelrys NASDAQ £- £- - ico_glass.png
Accurexa OTCBB £- £- - ico_glass.png
AcelRx Pharmaceuticals NASDAQ £145.42m £2.35 -6.67% ico_glass.png
Acer Therapeutics PRIVATE £- £- - ico_glass.png
Achaogen NASDAQ £66.33m £1.44 4.05% ico_glass.png
Achillion Pharmaceuticals NASDAQ £353.30m £2.55 4.59% ico_glass.png
Acrux ASX £20.17m £0.12 10.53% ico_glass.png
Actinogen Medical Ltd ASX £29.66m £0.03 -2.13% ico_glass.png
Acuity Bio PRIVATE £- £- - ico_glass.png
Adherium ASX £5.22m £0.03 6.12% ico_glass.png
Adial Pharmaceuticals Inc NASDAQ £10.63m £1.62 3.57% ico_glass.png
ahz[LOGO]200x100.jpg Admedus Ltd ASX £13.84m £0.04 0.00% ico_glass.png
Advanced Medical Solutions Group AIM £619.09m £2.90 1.75% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy PLC LSE £61.04m £0.36 0.00% ico_glass.png
Advantis Corporation PINK £0.98m £0.03 3.55% ico_glass.png
AEQUUS.png Aequus Pharmaceuticals Inc TSX-V £7.21m £0.09 -3.23% ico_glass.png
Aethlon Medical Inc NASDAQ £19.03m £1.04 2.36% ico_glass.png
Aetna NYSE £55,639.40m £169.94 0.33% ico_glass.png
Affymax NASDAQ £- £- - ico_glass.png
AFP Imaging PINK £0.02m £0.57 -25.52% ico_glass.png
Agenix Limited ASX £- £- - ico_glass.png
Agenus NASDAQ £254.99m £2.13 1.53% ico_glass.png
Agility Health TSX-V £1.27m £0.01 0.00% ico_glass.png
Agios Pharmaceuticals NASDAQ £2,605.40m £44.78 2.79% ico_glass.png
AGTC NASDAQ £95.05m £5.24 7.37% ico_glass.png
AirXpanders ASX £3.11m £0.02 3.57% ico_glass.png
Akers Biosciences, Inc. AIM £16.22m £1.30 -7.14% ico_glass.png
Akorn NASDAQ £434.15m £3.46 0.93% ico_glass.png

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.